共 50 条
- [1] Comparative effectiveness of vedolizumab and ustekinumab as induction therapy in anti-TNF refractory Crohn's disease: a multi-centre retrospective cohort study [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 : S407 - S408
- [3] Comparative Effectiveness of Vedolizumab Versus Ustekinumab in Anti-TNF Experienced Patients With Crohn's Disease [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S676 - S676
- [4] Effectiveness of ustekinumab and vedolizumab in patients with Crohn's disease refractory to anti-tumour necrosis factor: A multi-centre comparative study [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S118 - S120
- [7] Effectiveness of ustekinumab in fistulising perianal Crohn's disease refractory or intolerant to anti-TNF [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S419 - S420
- [10] Effectiveness of ustekinumab after vedolizumab failure in patients with anti-TNF-refractory Crohn's disease [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S528 - S528